T ransmissible spongiform encephalopathies (TSEs), 3 or "prion diseases," are subacute neurodegenerative diseases that affect humans and both domestic and free-ranging animals. The neuropathological features within the CNS characteristically include spongiform pathology, neuronal loss, glial activation, and amyloidal aggregations of an abnormally folded host protein. There is little evidence of pathology in other tissues. The host prion protein (PrP c ) is widely expressed in both humans and animals, and its expression is crucial for TSE disease susceptibility (1) . In TSE-affected tissues, the PrP accumulates as an abnormal, detergent-insoluble, relatively proteinase-resistant isoform, termed PrP Sc . TSE agent infectivity copurifies with PrP Sc (2) and is considered to be a major or possibly sole component of the infectious TSE agent. Indeed, the prion hypothesis argues that PrP Sc is itself the infectious agent and facilitates conversion of cellular PrP c to PrP Sc .
TSE diseases typically have long incubation periods before the onset of clinical signs, which in humans can vary from 1.5 to at least 40 years. Following peripheral exposure, many of the acquired TSE agents accumulate in lymphoid tissues such as the spleen, lymph nodes, tonsils, appendix, and Peyer's patches (PPs), before spreading to the CNS, a process termed neuroinvasion. Examples include sheep with natural scrapie (3), mule deer with chronic wasting disease (4) , and humans with variant CreutzfeldtJakob disease (vCJD) (5) . Within the lymphoid tissues of both experimentally and naturally affected hosts, early PrP Sc accumulation occurs within the germinal centers upon follicular dendritic cells (FDCs) and within tingible body macrophages (4 -9) . FDCs are a distinct lineage from migratory bone marrow-derived dendritic cells because they are considered to derive from stromal precursor cells, are nonphagocytic, and are nonmigratory (10) . In mouse scrapie models, mature FDCs are critical for scrapie agent accumulation in lymphoid tissues, and in their absence, neuroinvasion is significantly impaired (11) (12) (13) (14) . From the lymphoid tissues, translocation to the CNS occurs via the peripheral nervous system (15, 16) .
The suggestion that consumption of bovine spongiform encephalopathy-contaminated meat products is the most likely cause of vCJD in humans (17) has focused attention on the gastrointestinal tract as an important portal of TSE entry. Following intragastric or oral inoculation of rodents with scrapie, infectivity and PrP Sc accumulate first in PPs, mesenteric lymph nodes (MLNs), and ganglia of the enteric nervous system long before their detection in the CNS (18, 19) . Natural sheep scrapie may also be acquired orally as PrP Sc is detected in the GALT before detection within the CNS (6) . Likewise, PrP
Sc is first detected in the GALT following experimental oral inoculation of mule deer fawns (Odocoileus hemionus) with chronic wasting disease (4) . The detection of disease-specific PrP within the GALT of a human vCJD patient 8 mo before the onset of clinical signs is also consistent with the transmission of this disease by the oral route (5).
The GALT comprises chiefly of appendix, tonsils, PPs, MLNs, and ILFs, but which if any of these tissues are crucial for the oral pathogenesis of TSEs is unclear. Previous studies have used a variety of immunodeficient mouse lines to study the involvement of FDCs and PPs in oral scrapie pathogenesis, including TNF-␣ Ϫ/Ϫ ϫ lymphotoxin (LT)␣ Ϫ/Ϫ mice, aly/aly mice, ␤7 Ϫ/Ϫ mice, RAG-1 Ϫ/Ϫ mice, and MT Ϫ/Ϫ mice (20 -22) . However, the individual contributions of the deficiencies in lymphoid tissue, lymphoid tissue microarchitecture, or FDC development were not distinguished in the same mouse strains. In the current study, mouse models were created that lacked specific GALT components (PPs, MLNs, and ILFs) but had mature FDC networks in the remaining lymphoid tissues. The presence of FDCs in the remaining lymphoid tissues ensured that TSE agent accumulation could occur within these tissues if the missing tissues were not critical to disease pathogenesis. Using these mouse models, experiments were designed to address the following questions: first, whether TSE susceptibility is reduced in the absence lymphoid tissue within the intestine itself (e.g., PPs)? Second, whether neuroinvasion occurs from multiple sites such that the lack of one compartment (e.g., PPs) can be compensated for by the presence of another (e.g., MLNs)? Third, whether neuroninvasion can occur via other lymphoid tissues (e.g., spleen) in the absence of the GALT?
Materials and Methods

Mice
LT␣
Ϫ/Ϫ mice (23) and LT␤ Ϫ/Ϫ mice (24) were obtained from B&K Universal and were maintained on a C57BL/6 background. Age-and sexmatched C57BL/6 mice were used as immunocompetent wild-type (WT) controls in studies using LT␣ Ϫ/Ϫ mice and LT␤ Ϫ/Ϫ mice.
Gamma irradiation and bone marrow reconstitution
Bone marrow from the femurs and tibias of immunocompetent C57BL/6 WT mice was prepared as a single-cell suspension (3 ϫ 10 7 -4 ϫ 10 7 viable cells/ml) in HBSS (Invitrogen Life Technologies). Recipient adult (6 -8 wk old) LT␣ Ϫ/Ϫ mice, LT␤ Ϫ/Ϫ mice, and C57BL/6 mice were gamma irradiated (950 rad) and 24 h later reconstituted with 0.1 ml of bone marrow by injection into the tail vein.
PP-deficient mice
To create progeny mice deficient in PPs, timed pregnant C57BL/Dk mice were given a single i.v. injection of 100 g of a fusion protein containing the soluble LT␤R domain linked to the Fc portion of human IgG1 (LT␤R-Ig; Ref 25) on day 11.5 of gestation (26) .
Scrapie agent inoculation
For oral inoculation mice were fed individual food pellets doused with 50 l of a 1.0% (w/v) scrapie brain homogenate prepared from mice terminally affected with ME7 scrapie. Where indicated, separate groups of mice were inoculated by intracranial injection with 20 l of a 1.0% (w/v) scrapie mouse brain homogenate (containing ϳ1 ϫ 10 4.5 ID 50 units). Following challenge, animals were coded and assessed weekly for signs of clinical disease and killed at a standard clinical end point (27) . Scrapie diagnosis was confirmed by histopathological assessment of vacuolation in the brain. Where indicated, some mice were sacrificed 70 days postchallenge, and small intestines, MLNs, and spleens taken for further analysis. For the construction of lesion profiles, vacuolar changes were scored in nine graymatter areas of brain as described previously (28) .
Immunohistochemical and immunofluorescent analysis
Spleens and MLNs were removed and snap-frozen at the temperature of liquid nitrogen. Small intestines from each mouse were divided into three roughly equal parts, gently squeezed to remove gut contents, coiled, embedded in Tissue-Tek OCT Compound (Bayer), and snap-frozen at the temperature of liquid nitrogen. Serial frozen sections (10 m in thickness) were cut on a cryostat. FDCs were visualized by staining with mAb 8C12 to detect CR1 (CD35) or mAb 7G6 to detect CR2/CR1 (CD21/CD35; BD Biosciences Pharmingen). Complement components C3 and C4 were detected using mAb RMC7H8 (Connex) and mAb FDC-M2 (AMS Biotechnology), respectively. Cellular PrP c was detected using PrP-specific polyclonal Ab (pAb) 1B3 (29) . B lymphocytes were detected using mAb B220 to detect CD45R (Caltag Laboratories). M cells were detected using biotinconjugated Ulex europaeus agglutinin I (UEA-1; Vector Laboratories). Lymphatic vessels were detected using lymphatic vessel endothelial hyaluronic acid receptor (LYVE-1)-specific antiserum (Upstate Biotechnology). Nerve fibers and supportive cells were detected using S100-specific antiserum (DakoCytomation).
For the detection of disease-specific PrP (PrP d ) in brain tissue and small intestines, tissues were fixed in periodate-lysine-paraformaldehyde and embedded in paraffin wax. Sections (thickness, 6 m) were deparaffinized and pretreated to enhance PrP immunostaining by hydrated autoclaving (15 min, 121°C, hydration), and subsequent immersion in formic acid (98%) for 5 min (7). This pretreatment enhances the detection of PrP d . Sections were then stained with the PrP-specific pAb 1B3 (29) . Glial fibrillary acid protein (GFAP) was detected on adjacent brain sections using rabbit GFAP-specific antiserum (DakoCytomation). To detect FDCs and B lymphocytes in paraffin-embedded small intestines, sections were deparaffinized and pretreated with Target Retrieval Solution (DakoCytomation) and immunostained with mAb 7G6 and mAb B220, respectively, as described above.
For light microscopy, following the addition of primary Abs, biotinconjugated species-specific secondary Abs (Stratech) were applied followed by alkaline phosphatase or HRP coupled to the avidin/biotin complex (Vector Laboratories). Vector Red (Vector Laboratories) and diaminobenzidine were used as substrates, respectively, and sections were counterstained with hematoxylin to distinguish cell nuclei. For fluorescent microscopy, following the addition of primary Ab, species-specific secondary Abs coupled to Alexa Fluor 488 (green) or Alexa Fluor 594 (red) dyes (Invitrogen Life Technologies) were used. Sections were mounted in fluorescent mounting medium (DakoCytomation) and examined using a Zeiss LSM5 confocal microscope (Zeiss).
ILF enumeration and analysis
Entire small intestines from each mouse were divided into three equal parts, coiled, fixed in paraformaldehyde, and embedded in paraffin wax. Serial sections (10 m in thickness) were deparaffinized and immunostained with antisera specific for CD45R or CR2/CR1 as described above and examined using a confocal microscope. The total number of B lymphocyte-containing ILFs in the entire small intestine of each mouse analyzed was counted microscopically using CD45R expression for identification. The maturity of each ILF was determined according to size and the location and density of component cells as described previously (30) . The presence or absence of FDCs (CR2/CR1 ϩ CD45R Ϫ cells) within each ILF was recorded.
Immunoblot detection of PrP Sc
Spleen fragments (ϳ20 mg) or MLNs (approximately half the total from each mouse assayed) were prepared as 10% (w/v) tissue homogenates, and PrP Sc was enriched by sodium phosphotungstic acid precipitation (31) and treated in the presence or absence of proteinase K (40 g/ml, 60 min, 37°C; VWR). Following enrichment, pellets were resuspended and diluted to 0.5 mg protein/ml, and 10 l was electrophoresed through SDS-PAGE gels (12%) polyacrylamide gels (Invitrogen Life Technologies). Proteins were transferred to polyvinylidene difluoride membranes (Bio-Rad) by semidry blotting. PrP was detected with the PrP-specific mouse mAb 8H4 (32), followed by HRP-conjugated goat anti-mouse antiserum. Bound HRP activity was detected with Supersignal West Dura Extended Duration Substrate (Pierce).
Statistical analysis
Data are presented as mean Ϯ SE. Significant differences between samples in different groups were sought by one-way ANOVA. Values of p Ͻ 0.05 were accepted as significant.
Results
Effect of lymphotoxin deficiency on scrapie accumulation in lymphoid tissues
The intestines of LT␣ Ϫ/Ϫ mice and LT␤ Ϫ/Ϫ mice lack PPs as LT␤R signaling during embryonic development is required for their formation (30, 33, 34) . In addition LT␣ Ϫ/Ϫ mice also lack the MLNs as LT␣ deficiency blocks their formation (34) . However, postnatal stimulation via lymphocyte-derived LT␣ 1 ␤ 2 is critically required to maintain FDCs in their differentiated state (35) . As a consequence, the remaining MLNs and spleens of LT␤ Ϫ/Ϫ mice ( Ϫ/Ϫ mice. In this study, the normal cellular form of the PrP is referred to as PrP c , and two terms (PrP Sc or PrP d ) are used to describe the disease-specific, abnormal accumulations of PrP that are characteristically found only in TSE-affected tissues and considered to represent the presence of the TSE agent (2). Disease-specific PrP accumulations are relatively resistant to proteinase digestion, whereas cellular PrP c is destroyed by this treatment. Where we were able to confirm this resistance by proteinase K treatment of samples and analysis by immunoblot, PrP
Sc is used as a biochemical marker for the presence of the TSE agent. Unfortunately, treatment of tissue sections with proteinase K destroys the microarchitecture. Therefore, tissue sections were fixed and pretreated to enhance the detection of the disease-specific abnormal accumulations of PrP (PrP d ), whereas cellular PrP c is denatured by these treatments (7) . We have shown in a series of studies that these PrP d accumulations occur only in the tissues of TSE-affected animals and correlate closely with the presence of the TSE agent (7, 8, 11, 13, 19 
Effect of lymphotoxin deficiency on scrapie susceptibility
We next determined the effect of the combined GALT and FDC deficiency in LT␣ Ϫ/Ϫ mice and LT␤ Ϫ/Ϫ mice on scrapie susceptibility. All orally inoculated WT mice succumbed to clinical TSE disease with a mean incubation period of 311 Ϯ 3 days (n ϭ 20; Table I ). In contrast, LT deficiency dramatically affected scrapiesusceptibility as all LT␣ Ϫ/Ϫ mice (n ϭ 13) and LT␤ Ϫ/Ϫ mice (n ϭ 18) remained free of the signs of scrapie up to at least 545 days after oral inoculation (Table I) . Characteristic PrP d accumulation, reactive astrocytes, and spongiform pathology were detected in the brains of all clinically affected WT mice (Fig. 3A) . The severity and distribution of the pathological vacuolation within the brains of WT mice was typical for oral infection with the ME7 scrapie strain (Fig. 3B) . However, none of the pathological . Samples were treated in the presence (ϩ) or absence (Ϫ) of proteinase K (PK) before electrophoresis. After PK treatment, a typical three-band pattern was observed between molecular mass values of 20 -30 kDa, representing unglycosylated, monoglycosylated, and diglycosylated isomers of PrP (in order of increasing molecular mass). dpi, day postinoculation on which the tissues were analyzed; pos, mice that developed clinical signs of scrapie; neg, mice that were free of the signs of scrapie.
characteristics of TSE disease were detected within the brains of any of the surviving LT␣ Ϫ/Ϫ mice and LT␤ Ϫ/Ϫ mice (Fig. 3,  A and B) .
When inoculated with the scrapie agent directly into the CNS (by intracranial injection) WT mice, LT␣ Ϫ/Ϫ mice, and LT␤ Ϫ/Ϫ mice developed clinical scrapie with similar incubation periods of 172-175 days (Table I ). These data confirm that the apparent resistance of LT␣ Ϫ/Ϫ mice and LT␤ Ϫ/Ϫ mice to orally inoculated scrapie agent could not be attributed to a role for LT␤R signaling in the development of pathology within the CNS. Ϫ/Ϫ mice and WT3 LT␤ Ϫ/Ϫ mice (C). All sections were counterstained with hematoxylin (blue). Original magnification: ϫ200. dpi, day postinoculation on which the tissues were analyzed; pos, mice that developed clinical signs of scrapie; neg, mice that were free of the signs of scrapie. B and D, Pathological assessment of the spongiform change (vacuolation) in brains from terminally scrapie-affected mice and mice that remained free of the signs of disease at the end of the experiment. Vacuolation was scored on a scale of 0 -5 in the following gray matter (G1-G9) areas: G1, dorsal medulla; G2, cerebellar cortex; G3, superior colliculus; G4, hypothalamus; G5, thalamus; G6, hippocampus; G7, septum; G8, retrosplenial and adjacent motor cortex; G9, cingulate and adjacent motor cortex. Each point represents mean vacuolation score Ϯ SE for groups of 6 -20 mice. a Number of mILFs present in the small intestine at the time of inoculation. b Incidence ϭ number of animals affected/number of animals tested. The notation "NX Ͼ 545" means that mice were free of the clinical and pathological signs of scrapie up to at least this time after inoculation.
c ϩ, present; Ϫ, absent.
Reconstitution of LT-deficient mice with WT bone marrow induces FDC development in remaining lymphoid tissues but not the development of missing lymphoid tissues
Next, the effects of GALT deficiency, but not FDC deficiency, on scrapie pathogenesis were investigated. Adult WT mice, LT␣ Ϫ/Ϫ mice, and LT␤ Ϫ/Ϫ mice were reconstituted with LT-expressing WT bone marrow (termed WT3 WT mice, WT3 LT␣ Ϫ/Ϫ mice, and WT3 LT␤ Ϫ/Ϫ mice, respectively). Within 35 days of WT bone marrow transfer, FDC networks were induced in the remaining lymphoid tissues of LT␣ Ϫ/Ϫ mice and LT␤ Ϫ/Ϫ mice (Fig. 4A ), but such treatment did not induce the development of missing lymphoid tissues (Table II) (Fig. 4B) . (Fig. 5A ) and were maintained until the terminal stage of disease (Fig. 5B) (Fig. 6A) , although PrP Sc was detected in one of the spleens from a WT3 WT mice taken at this time (Fig.  6B, lane 2) . At the terminal stage of disease strong accumulations of PrP Sc were found in the MLNs and spleens of WT3 WT mice (Fig. 6, C and D) . However, the accumulation of PrP Sc in the MLNs (where present) and spleens of WT3 LT␣ Ϫ/Ϫ mice and WT3 LT␤ Ϫ/Ϫ mice remained undetectable (Fig. 6, C and D) . We next determined the effect of MLN and/or PP deficiency on disease susceptibility. All orally inoculated WT3 WT mice succumbed to clinical TSE disease with a mean incubation period of 337 Ϯ 4 days (n ϭ 8, Table II ). In contrast, in the absence of both PPs and MLNs, scrapie susceptibility was dramatically affected as all orally inoculated WT3 LT␣ Ϫ/Ϫ mice (n ϭ 8) remained free of the signs of scrapie up to at least 503 days after inoculation (Table  II) . Furthermore, in the absence of PPs alone, scrapie susceptibility was also dramatically affected as all WT3 LT␤ Ϫ/Ϫ mice (n ϭ 7) remained free of clinical scrapie (Table II) . Typical neuropathological characteristics of TSE infection were detected within the brains of all WT3 WT animals that developed clinical signs of scrapie (Fig. 3, C and D) . None of these characteristics were detected within the brains of any of the surviving WT3 LT␣ Ϫ/Ϫ mice and WT3 LT␤ Ϫ/Ϫ mice (Fig. 3, C and D) . In this study, a highly sensitive immunoblot method was used to detect PrP Sc in our tissue samples (31) . Therefore, we are confident that in this study the combined absence of 1) PrP Sc in the GALT and spleen, 2) PrP d and neuropathological signs within the CNS, and 3) clinical signs of TSE disease, is convincing evidence that transmission was blocked in scrapie-inoculated LT␣ Ϫ/Ϫ mice, LT␤ Ϫ/Ϫ mice, WT3 LT␣ Ϫ/Ϫ mice, and WT3 LT␤ Ϫ/Ϫ mice. 
Scrapie pathogenesis in the absence of MLNs and/or PPs
Mice were inoculated orally with the scrapie agent 35 days after gamma irradiation and reconstitution with WT bone marrow.
b Number of mILFs present in the small intestine at the time of inoculation. c ϩ, present; Ϫ, absent. d Three mice were killed 406, 450, and 467 days after inoculation. These mice were free of the clinical signs of scrapie at the time of cull. No histopathological signs of scrapie were detected in the brain (data not shown).
e Three mice were killed 413, 455, and 455 days after inoculation. These mice were free of the clinical signs of scrapie at the time of cull. No histopathological signs of scrapie were detected in the brain (data not shown).
Mature ILFs contain FDCs
Novel lymphoid clusters termed ILFs have been identified along the antimesenteric wall of the mucosa of the intestine (36) . The maturity of ILFs has previously been defined according size and the location and density of component cells (30) . Whereas immature ILFs (iILFs) comprise loosely clustered CD45R ϩ (B220) cells located at the base of villi (Fig. 7A) , mature ILFs (mILFs) are organized nodular structures, of width greater than one villus and comprise a single B lymphocyte follicle (Fig. 7A) with an overlying M cell-containing epithelium similar to the follicle associated epithelium of PPs (Fig. 7D) . Using these criteria, double immunostaining for B lymphocytes (CD45R ϩ cells) and FDCs (CR2/ CR1 ϩ CD45R Ϫ cells) on the same tissue section revealed that the presence of FDCs could also be reliably used to distinguish ILF . Samples were treated in the presence (ϩ) or absence (Ϫ) of proteinase K (PK) before electrophoresis. dpi, day postinoculation on which the tissues were analyzed; pos, mice that developed clinical signs of scrapie; neg, mice that were free of the signs of scrapie. maturation status. In this study, Ͼ1000 ILFs were analyzed, and our data showed that all mILFs consistently possessed large networks of immune complex-trapping FDCs (Fig. 7, A and B) . FDCs were never detected in iILFs (Fig. 7, A and C) . Like PPs, ILFs lack afferent lymphatics, but LYVE-1-expressing cells were observed in close association with ILFs, indicating the presence of efferent lymphatics (Fig.   7E ). S-100-expressing nerve fibers and supportive cells were detected within the gut wall and in close association with mILFs (Fig. 7F) .
Involvement of mILFs in scrapie agent neuroinvasion from the intestine
Having demonstrated that mILFs contain large FDC networks we next determined whether scrapie agent neuroinvasion from the intestine could also occur from mILFs. Stimulation via LT␤R is also important for the development of ILFs as these structures are absent in LT-deficient mice (30, 36) . However, unlike PPs, ILF formation occurs postnatally, and their development in LT-deficient mice can be restored by reconstitution with WT bone marrow (30, 36 ). In the experiments described above (Table II) , no FDC-containing mILFs were present within the intestines of WT3 WT mice, WT3 LT␣ Ϫ/Ϫ mice, and WT3 LT␤ Ϫ/Ϫ mice at the time of scrapie inoculation, as these structures take much longer than 35 days to develop after WT bone marrow transfer (ϳ8 -12 wk; Refs. 30 and 37). The numbers of mILFs in the intestines of immunocompetent control mice in our specific pathogen-free colony are extremely low or absent (typically 0 -6 mILFs/mouse). However, in the absence of PPs, LT␤R stimulation substantially increases the number of mILFs in the intestine (30) . We therefore created mice that lacked PPs but contained numerous mILFs in their intestines through treatment of pregnant C57BL/Dk mice with LT␤R-Ig (26, 30) . As expected, PP formation in the progeny mice was blocked (termed PPdeficient mice), but the development of a significantly greater number of FDC-containing mILFs was induced when compared with untreated C57BL/Dk (control) mice ( p Յ 0.001; Table III) .
Control and PP-deficient mice (81-110 days old) were inoculated orally with the scrapie agent. Strong accumulations of PrP d were observed upon FDCs within each of the numerous mILFs of PP-deficient mice (ϳ20 mILFs per PP-deficient mouse, n ϭ 14) and the PPs and occasional mILFs in control mice within 70 days of oral inoculation (Fig. 8A) and at the terminal stage of disease (Fig. 8B) . PrP d accumulations were never observed within iILFs from each mouse group.
In the MLNs, PrP Sc was detected in all tissues from control mice 70 days after inoculation, but the levels detected in tissues from PP-deficient mice were variable (Fig. 9A) . However, high levels of PrP Sc levels were detected in MLNs from each mouse group at the terminal stage of disease (Fig. 9C) . No PrP Sc was detected in any of the spleens taken from control mice and PP-deficient mice 70 days after inoculation (Fig. 9B) , but strong accumulations were observed at the terminal stage of disease (Fig. 9D) .
Additional experiments demonstrated that the susceptibility of PPdeficient mice to orally inoculated scrapie agent was not significantly affected, as all control mice and PP-deficient mice succumbed to clinical TSE disease with similar incubation periods (Table III) and displayed similar neuropathological characteristics within the brain (data not shown). Together, these data imply that FDCs within mILFs are also important sites of TSE agent neuroinvasion from the intestine.
Discussion
In this study, we show that in the combined absence of the GALT and FDCs at the time of inoculation, scrapie agent transmission from the gastrointestinal tract is blocked. Furthermore, when FDC maturation is induced in remaining lymphoid tissues, mice that lack PPs remain refractory to oral scrapie challenge. Although the scrapie agent also accumulates upon FDCs within the MLNs shortly after inoculation, our data show that MLNs are dispensable for TSE agent neuroinvasion from the intestine. We show that mILFs along the antimesenteric wall of the small intestine contain large FDC networks, and like PPs, are important sites of TSE agent neuroinvasion. Together, these data demonstrate that TSE agent accumulation upon FDCs within GALT in the intestine itself (e.g., PPs and mILFs) is critically required for efficient neuroinvasion following oral exposure.
When considered in the context of recent studies, our data suggest that TSE agent neuroinvasion from the intestine occurs via the following pathway. Following oral inoculation, FDCs are critical initial sites of TSE agent accumulation within the GALT (13) . In the absence of FDCs at the time of inoculation, TSE agent accumulation in the PP and subsequent neuroinvasion are blocked (13) . In the current study, we show that in the absence of PPs, but not FDCs within other lymphoid tissues, neuroinvasion is likewise blocked indicating a critical role for PPs and the FDCs within them in TSE agent neuroinvasion from the intestine. We also show that mILFs, like PPs, are novel and important sites of TSE agent neuroinvasion from the intestine. Because the number and maturation status of ILFs is dramatically influenced by luminal stimuli (30, 38, 39) , our data suggest that the presence of mILFs will significantly affect TSE susceptibility. Although early TSE agent accumulation also occurs within the MLNs following oral inoculation, we demonstrate that their presence does not influence disease pathogenesis. Likewise, FDCs within the spleen were also unable to compensate for the absence of the PPs. Together these data imply that neuroinvasion most likely occurs directly from lymphoid tissue within the intestine following accumulation upon FDCs. This conclusion is congruent with data from an epidemiological, mathematical, and pathological study, which suggested that for sheep, cattle, and humans, there was an association between development of lymphoid tissues in the gastrointestinal tract and susceptibility to natural TSE infection (40) . The precise role that FDCs play in TSE pathogenesis awaits definitive demonstration, but they appear to amplify the levels of the TSE agent above the threshold required to achieve neuroinvasion (11) (12) (13) (14) . When and how the TSE agent spreads from the FDCs within PPs to the peripheral nervous system is likewise unknown. FDC depletion 14 days after oral inoculation does not affect pathogenesis, implying that neuroinvasion occurs from a very early stage postexposure and before the agent has disseminated to other lymphoid tissues (13) . We show that within mILFs, like PPs (19) , FDC networks are situated in close association with the nerve fibers that run along the gut wall. As the distance between FDCs and peripheral nerves appears to modulate the rate of TSE agent neuroinvasion (16) , it is likely that the close association of FDCs with the nerve fibers that run along the gut wall facilitates the rapid spread of the TSE agent from PPs and mILFs to neighboring enteric nerves. Indeed, studies have demonstrated that PrP d accumulates within enteric ganglia soon after oral inoculation (19) .
How TSE agents are initially acquired from the gut lumen and cross the intestinal epithelium is not known, but several mechanisms have been implicated including transcytosis by M cells (41) and possibly also capture and transport by migratory bone marrowderived dendritic cells (42) . In the current study, any potential effects on dendritic cell migration to the spleen, due to a lack of LT␣ 1 ␤ 2 expressing B lymphocytes (43) , were restored by WT bone marrow reconstitution. However, our data cannot exclude the possibility that the lack of M cells within the follicle associated epithelia of LT␣ Ϫ/Ϫ mice, LT␤ Ϫ/Ϫ mice, WT3 LT␣ Ϫ/Ϫ mice, and WT3 LT␤ Ϫ/Ϫ mice at the time of inoculation also contributes to their resistance to orally inoculated scrapie agent.
The inability of the MLNs or spleen to compensate for the absence of the PPs is unlikely to be due to fundamental differences in the nature of the FDCs at each of these sites as no significant differences between the function of FDCs from these tissues has been described, and each population appears to express similar levels of PrP c and CR1/CR2. Following oral inoculation, the TSE agent accumulates first in PPs and is subsequently distributed via the lymph and/or blood-stream to the MLNs and spleen (Ref. 13 and current study). In the absence of the PPs, our data show that this down-stream distribution is blocked.
Diet (e.g., consumption of TSE agent-contaminated food) and PrP genotype (44, 45) are important risk factors that affect TSE susceptibility, but others remain to be determined. Recent studies suggest that inflammation may be another factor, either enhancing agent uptake from mucosal sites (46) , or expanding the tissue distribution of these agents (47) (48) (49) . For example, the induction of FDC networks within the ectopic germinal centers of chronically inflamed kidneys enables the accumulation of high levels of PrP Sc in this tissue and excretion of low levels of infectivity in urine (47, 48) . Likewise, natural chronic inflammatory conditions can expand the deposition of PrP Sc in TSE-affected animals, such as to inflamed mammary glands of scrapie-affected sheep (49) .
ILFs are recently identified lymphoid structures distributed throughout the intestines of rodents (36, 50 -52) and humans (53) with features similar to PPs. Although the small intestine of an adult mouse may contain as many as 100 ILFs, data from the current study and others (30, 37) show that mILFs are highly infrequent (typically Ͻ5 per mouse) in tissues from unmanipulated immunocompetent control mice in a specific pathogen-free colony. Stimulation via LT␤R is also important for the development of ILFs, but unlike PPs, their formation occurs postnatally (30, 37) . In response to exogenous stimuli, LT-expressing B lymphocytes trigger the progression of iILFs into mILFs resembling lymphoid nodules containing a single B lymphocyte follicle of predominantly B2-B lymphocytes with a germinal center and a follicle associated epithelium containing M cells (30, 37, 54) . Our analysis also demonstrates that mILFs consistently contain large FDC networks, which are not present in iILFs. Because the inducible nature of mILFs (30, 38) shares features with the ectopically induced germinal centers described above (47-49) we reasoned that mILFs might represent an important novel site of TSE agent accumulation and neuroinvasion in the small intestine.
To specifically determine the potential involvement of mILFs in scrapie agent transmission from the gastrointestinal tract, temporary in utero blockade of the LT␤R signaling pathway was used to create mice that lacked PPs (termed PP-deficient mice), but contained numerous mILFs (26, 30) . Our experiments demonstrate that FDCs within mILFs are novel and important sites of TSE agent accumulation within the small intestine. Furthermore, due to the presence of a significantly larger number of FDC-containing mILFs in PP-deficient mice, disease susceptibility was unaffected by the absence of PPs. The formation and maturation status of ILFs can be modulated by both lumenal bacterial flora (30, 38) and pathogenic microorganisms (39) , implying that the microbiological status of the intestine at the time of TSE agent exposure might dramatically enhance disease susceptibility.
In the current study, our animals eat the scrapie agent to model oral pathogenesis as closely as possible. Following ingestion of the scrapie agent many factors will act on the inoculum to aid its elimination from the host. Indeed, much of the inoculum will be eliminated from the host by factors including digestion (by enzymes secreted in the stomach or small intestine) and excretion. As a consequence, following oral inoculation very little of the original inoculum will be available to be translocated across the gut epithelium by M cells or other potential mechanisms (41, 42) . In WT mice it is likely that once the remaining fraction of the inoculum enters the lamina propria a competitive state exists whereby cells such as macrophages aid the clearance of the TSE agent (55, 56) , whereas FDCs act to expand the levels of the TSE agent above the threshold required to achieve neuroinvasion. Thus, in the absence of FDCs (and lymphoid tissue within the intestine) in LT-deficient mice, the residual fraction of the inoculum will be gradually destroyed by phagocytic cells (55, 56) . We have previously shown that the temporary depletion of FDCs for ϳ21-28 days blocks TSE agent transmission from the intestine (13) , suggesting this time interval is sufficient to allow clearance of the remaining inoculum. In the current study, no mILFs were detected in the small intestines of WT3 LT␣ Ϫ/Ϫ mice and WT3 LT␤ Ϫ/Ϫ mice at the time the mice were inoculated with the scrapie agent (5 wk after bone marrow reconstitution) as their formation occurs between 8 and 12 wk after WT bone marrow reconstitution (30, 37) . Therefore, by the time the mILFs had eventually developed in the intestines of WT3 LT␣ Ϫ/Ϫ mice and WT3 LT␤ Ϫ/Ϫ mice, sufficient time will have elapsed to allow clearance of the remaining inoculum, preventing PrP d accumulation upon the FDCs within them and subsequent neuroinvasion.
In conclusion, our data demonstrate the crucial importance of TSE agent accumulation upon FDCs within the GALT for efficient neuroinvasion following oral exposure. Current evidence suggests vCJD shares a similar requirement for accumulation upon FDCs before neuroinvasion (5) . Thus, our data imply that neuroinvasion of the vCJD agent might also occur soon after accumulation within the GALT before the agent has disseminated to other lymphoid tissues. Our data also identify mILFs as a novel and important site of TSE agent accumulation within the small intestine. As the formation and maturation status of ILFs is strongly influenced by commensal and pathogenic microorganisms (30, 38, 39) , factors that stimulate mILF development are likely to dramatically enhance susceptibility to orally acquired TSE agents.
